Core Viewpoint - The company Meihao Medical (301363.SZ) announced a share reduction plan involving major shareholders and executives, which will not affect the company's control or governance structure [1][4]. Shareholder Reduction Plan - Major shareholders including Shenzhen Meitai Lian Industrial Co., Ltd. (7.6291%), Shenzhen Meichuang United Investment Partnership (7.2477%), Shenzhen Meichuang Yintai Industrial Partnership (6.3322%), and Shenzhen Meichuang Jinda Investment Partnership (5.4930%) plan to reduce their holdings by up to 14,220,200 shares (2.4997% of total shares) within three months after the announcement [1][2][3]. - The reduction will occur through centralized bidding (up to 2,843,100 shares) and block trading (up to 11,377,100 shares) [2]. Executive Share Reduction - Executives including Deputy General Managers Yan Jun'e, Huang Kai, Yan Bo, and Director Joel Chan plan to reduce their holdings by a total of 54,264 shares (0.0095% of total shares) through centralized bidding [2][3]. Financial Implications - The total cash amount from the planned share reduction is approximately 463 million yuan, based on the closing price of 32.45 yuan per share on January 19 [4]. - Meihao Medical was listed on the Shenzhen Stock Exchange on October 12, 2022, with an initial public offering price of 30.66 yuan per share, raising a net amount of 122.48 million yuan [4][5].
美好医疗实控人方及高管拟套现4.6亿 2022上市募13.6亿